health
Bone Density Decrease
Adverse effectBone Density Decrease is an adverse health effect involving reduced bone mineral density over time. It describes a gradual change in the skeleton rather than an immediate symptom.
See how Bone Density Decrease is classified as a health effect and review the information associated with it.
These are research findings, not promises. Most options have little evidence, and results differ from person to person.
What can cause it
How likely each one is to cause it, most likely first.
Strength TrainingpracticePossible
Based on one study. Strongest study: a randomized controlled trial.
In a 2026 randomized trial of 62 people, arm aBMD decreased compared with usual care at 24 weeks.
Open the Strength Training page
The expert view shows every study, dose protocol and source.
What can cause it
Interventions reported to bring this on1 listedHighest probability
- →PracticesStrength TrainingCertaintyMediumSourceClinical1 other source
In a 2026 randomized trial of 62 people, arm aBMD decreased compared with usual care at 24 weeks (MD = −0.04 g/cm²; 95% CI −0.08 to −0.01; g = −0.506).
Who was studied
- People with a condition
Open Strength TrainingStudy result
aBMD in the arms decreased in the Diactive-1 group compared with the usual care group at 24 weeks (MD = −0.04 g/cm²; 95% CI −0.08 to −0.01; g = −0.506)
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Bone Density Decrease is an adverse health effect involving reduced bone mineral density over time. It describes a gradual change in the skeleton rather than an immediate symptom. Depending on the context, it may be associated with bone loss and increased fracture risk.
How interventions help
The interventions listed here are not described as improving bone density. Instead, the concern is that certain exposures may contribute to bone density decrease when they are excessive or sustained over time. The proposed pathways differ: chronic high caffeine intake is associated with increased urinary calcium excretion, while excessive consumption of Apple Cider Vinegar is linked to a possible chronic acid load. Long-term excessive preformed vitamin A, including from Vitamin A and Cod Liver Oil, is described as potentially impairing skeletal remodeling and increasing bone loss or fracture risk.
These findings point to duration and exposure level as important context. They describe changes that may develop over time rather than an immediate effect, and no specific onset period or persistence after stopping is provided. The information also does not establish that every use of these products causes bone density decrease; it concerns excessive, high, or chronic intake where those qualifiers are given. Vitamin B3 (Niacin) is mentioned in connection with this outcome, but the available description does not provide a mechanism or time course. Overall, the entries are best read as possible long-term risks associated with particular patterns of use, not as evidence that these products are intended to change bone density.
Choosing guidance
The main distinction between these options is the exposure pattern described, not a defined threshold. Apple Cider Vinegar is associated with excessive consumption, while Caffeine is discussed in terms of chronic high intake. Cod Liver Oil and Vitamin A both relate to long-term excessive intake of preformed vitamin A. Because no dose or time window is provided, these entries cannot show how much or how long would produce the effect.
This makes the information most relevant to people comparing sustained or excessive use, rather than judging a single serving or brief exposure. Cod Liver Oil may warrant consideration alongside Vitamin A because both descriptions involve preformed vitamin A and skeletal remodeling. Caffeine and Apple Cider Vinegar involve different exposure patterns and should not be treated as interchangeable options.
No listed option identifies a specific studied health status or a best study design, so the findings do not establish how well they apply to a particular population. Vitamin B3 (Niacin) is described through anecdotal reports, which is not enough to establish a reliable relationship with bone density. Overall, these entries are better suited to identifying exposure patterns that may merit review than to setting a personal intake limit or predicting individual risk.